Clinical Trials · NCT00191867
Clinical Trial of Teriparatide in Japan
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 160
- Start date
- Feb 2005
- Locations
- 6 sites, Japan
- Primary endpoint
- To assess the dose response of LY333334 with the percent change from baseline in lumbar spine mineral density at endpoint